Pill burden decreases and antiretroviral regimens simplify for many of the participants who start lenacapavir.

An oral HIV drug helped patients with center-involved diabetic macular edema achieve improvements in visual acuity, according ...

Adding lenacapavir to HIV treatment effectively simplified complicated regimens while lowering or maintaining virological ...

Merck said on Wednesday that its experimental oral HIV treatment was not inferior to Gilead's top-selling HIV drug Biktarvy ...

Gilead’s investigational drug combo bic/len could help lower the pill burden in patients with virologically suppressed HIV ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval ...

With HIV services shrinking across countries and prevention tools falling out of reach, UNAIDS says the world is at a ...

The first deliveries of lenacapavir to the African continent represent a turning point in the fight against HIV.

The global theme of World AIDS Day is “Overcoming disruption, transforming the AIDS response,” which aims to break down the ...

The ‘You, Me and HIV’ campaign was launched in January of 2025 and aims to tackle misconceptions surrounding a HIV diagnosis ...

Meanwhile, a new report from the European Centre for Disease Prevention and Control (ECDC) and World Health Organisation (WHO ...

HIV infections in Sri Lanka have increased despite a decline in cases globally, according to data released by the National ...